Tool
Supplement comparison tool
Pick up to 4 knowledge base entries and compare their dosage, price, evidence strength and ratings side by side — you can save or share a link to your selection.
Add to comparison (2/4)
| Category | Biohacking | Biohacking |
| Evidence strength | Early-stage evidence | Moderate evidence |
| Evidence Score | 2/5 | 3/5 |
| User rating | 3.6 (29) | 4.4 (79) |
| Typical dose | In Russian clinical practice: usually 10–20 mg twice daily; dosing in informal, uncontrolled sources varies more widely, with no clearly established, human-study-confirmed safe upper limit | — |
| Form | Tablets (Russian pharmaceutical preparation) or powder/capsules sold as a 'research chemical' outside Russia, without external quality control | — |
| Average price | Jako "research chemical": ok. 60–120 zł za opakowanie starczające na miesiąc, zależnie od źródła i braku standaryzacji | — |
| Monthly cost | ok. 60–120 zł/miesiąc, przy czym cena nie odzwierciedla kontrolowanej jakości produktu | — |
| Time to effects | Subjective effects are sometimes reported within days to a few weeks in informal user accounts, but no controlled study in healthy humans has confirmed a clear time course or the actual magnitude of any effect. | Not applicable — HRV is a monitoring indicator, not an intervention; changes in the trend become visible after several days to weeks of observation. |
| Who it's for | There's no well-established, solidly-evidenced target group in Western markets, where the substance isn't an approved drug | Athletes wanting to objectively monitor training load and recovery |